|
Laboratory findings
|
Disease severity of COVID-19
|
Statistic parameter
|
|---|
|
(mean ± SD)
|
AS (n = 11)
|
MS (n = 26)
|
SCS (n = 11)
|
F value
|
P value
|
|---|
|
Ct values
|
31.9 ± 2.6
|
31.0 ± 3.0
|
31.6 ± 2.8
|
0.398
|
0.674
|
|
B cells (%)
|
28.9 ± 14.8
|
13.3 ± 7.7
|
9.6 ± 6.6
|
7.018
|
0.002**
|
|
NK cells (%)
|
6.6 ± 5.1
|
3.8 ± 1.8
|
3.5 ± 1.1
|
1.286
|
0.286
|
|
CD 3 + T cells (%)
|
61.7 ± 7.8
|
63.9 ± 12.1
|
52.1 ± 13.2
|
4.079
|
0.024*
|
|
CD3 + CD4 + T cells (%)
|
33.3 ± 5.6
|
36.1 ± 9.7
|
30.3 ± 8.7
|
1.764
|
0.183
|
|
CD3 + CD8 + T cells (%)
|
23.1 ± 6.3
|
24.2 ± 10.5
|
17.0 ± 5.6
|
2.634
|
0.083
|
|
CD4 + /CD8 + ratio (%)
|
1.6 ± 0.8
|
1.8 ± 0.9
|
1.9 ± 0.8
|
1.764
|
0.183
|
|
IL2 (pg/mL)
|
4.8 ± 6.2
|
4.8 ± 4.1
|
8.3 ± 6.7
|
1.834
|
0.172
|
|
IL4 (pg/mL)
|
3.8 ± 2.6
|
3.8 ± 1.8
|
3.4 ± 1.1
|
0.161
|
0.852
|
|
IL5 (pg/mL)
|
5.9 ± 6.4
|
5.3 ± 4.4
|
6.3 ± 4.9
|
0.179
|
0.836
|
|
IL6 (pg/mL)
|
7.0 ± 10.2
|
6.0 ± 11.3
|
572.7 ± 1326.4
|
3.479
|
0.039*
|
|
IL8 (pg/mL)
|
52.9 ± 123.0
|
88.8 ± 90.8
|
885.7 ± 1920.0
|
3.348
|
0.044*
|
|
IL10 (pg/mL)
|
2.9 ± 1.1
|
2.7 ± 0.8
|
7.0 ± 7.6
|
5.819
|
0006**
|
|
TNF-α (pg/mL)
|
19.3 ± 43.6
|
58.2 ± 60.8
|
9.5 ± 7.5
|
4.689
|
0.014*
|
|
INF-α (pg/mL)
|
4.0 ± 3.9
|
5.7 ± 9.3
|
3.4 ± 0.7
|
0.451
|
0.640
|
|
INF-γ (pg/mL)
|
16.1 ± 34.8
|
26.9 ± 66.9
|
11.5 + 8.3
|
0.390
|
0.680
|
- One‐way analysis of variance. Statistically significant, *P < 0. 05, **P < 0.001
